Literature DB >> 2876150

DR2-negative narcolepsy.

A Andreas-Zietz, E Keller, S Scholz, E D Albert, B Roth, S Nevsimalova, K Sonka, P Docekal, E Ivaskova, H Schulz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876150     DOI: 10.1016/s0140-6736(86)90188-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Taq I-generated HLA-DQ alpha polymorphism in Japanese patients with narcolepsy.

Authors:  K Matsuki; H Maeda; T Juji; H Inoko; A Ando; K Tsuji; Y Honda
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 2.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

Review 3.  Genetic factors in sleep disorders.

Authors:  J D Parkes; C B Lock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 4.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

Review 5.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

6.  Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.

Authors:  M Onofrj; L Curatola; F Ferracci; T Fulgente
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

7.  Multiple sclerosis, sleep latencies and HLA antigens.

Authors:  L Rumbach; M M Tongio; J M Warter; M Collard; D Kurtz
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

8.  MHC class II sequences of an HLA-DR2 narcoleptic.

Authors:  C B Lock; A K So; K I Welsh; J D Parkes; J Trowsdale
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.